Centric Compounding Issues Nationwide Recall of Glutathione, Myer’s Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels
Company announcement
FOR IMMEDIATE RELEASE – 9/9/2026 – Houston, Texas, Centric Compounding is voluntarily recalling 6 lots of Glutathione 200mg/mL, Myer’s Cocktail, and Tri-Immune Boost injectable vials to the consumer level. The products have been found to be compounded with a Glutathione API containing elevated endotoxin levels .
Risk Statement: There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death. Centric Compounding has received 9 reports of fever, chills, chest pain, nausea/vomiting, headache, and/or malaise.
The products are used to support immunity, fatigue, and general wellness and are packaged in 30mL multidose vials . The affected Glutathione, Myer’s Cocktail, and Tri-Immune Boost lots include the following lot numbers and expiration dates :
| Product Name | Lot # | Beyond Use Date |
|---|---|---|
| Glutathione 200mg/ml 30mL vial | 062326:B | 8/7/26 |
| Glutathione 200mg/ml 30mL vial | 070826:A | 8/22/26 |
| Glutathione 200mg/ml 30mL vial | 072726:D | 9/25/26 |
| Myer's Cocktail 30mL vial | 070226:D | 8/16/26 |
| Myer's Cocktail 30mL vial | 072126:A | 9/4/26 |
| Tri-Immune Boost 30mL vial | 071626:B | 8/30/26 |
These products were distributed Nationwide to patients via home delivery and delivery to prescribers.
Centric Compounding is notifying its distributors and customers by email and is arranging for replacement of all recalled products. Consumers that have Glutathione, Myer’s Cocktail, and Tri-Immune Boost which is being recalled should stop using and discard any affected vials .
Consumers with questions regarding this recall can contact Centric Compounding by phone at 833-777-6664 or info@centriccompounding.com on Monday through Friday from 9am to 5pm CST . Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Official record — FDA enforcement
Official FDA enforcement data — classification, lot codes, and quantities — is published once FDA processes this recall, typically several weeks after the announcement. This page updates automatically when it arrives.